Evidence map›Paper›PMID 34746438›Full record

ArticleSynthetic biology (Oxford, England)2021

A CRISPR/Cas9 method facilitates efficient oligo-mediated gene editing in Debaryomyces hansenii.

Tomas Strucko, Niklas L Andersen, Mikkel R Mahler, José L Martínez, Uffe H Mortensen

Open access · goldAbstract read
In one paragraph

Article in Synthetic biology (Oxford, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. The role ofmBio · 2026
    Article
  2. Review
  3. The power of many: when genetics met yeasts and high-throughput.Biological reviews of the Cambridge Philosophical Society · 2026
    Review
  4. Review
  5. Review
  6. Review
  7. Regulation of Catalase Expression and Activity byJournal of fungi (Basel, Switzerland) · 2024
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Tomas StruckoDepartment of Biotechnology and Biomedicine, Section for Synthetic Biology, Technical University of Denmark, Kongens Lyngby, Hovedstaden, Denmark.ORCID https://orcid.org/0000-0003-1947-8138
Niklas L AndersenDepartment of Biotechnology and Biomedicine, Section for Synthetic Biology, Technical University of Denmark, Kongens Lyngby, Hovedstaden, Denmark.
Mikkel R MahlerDepartment of Biotechnology and Biomedicine, Section for Synthetic Biology, Technical University of Denmark, Kongens Lyngby, Hovedstaden, Denmark.
José L MartínezDepartment of Biotechnology and Biomedicine, Section for Synthetic Biology, Technical University of Denmark, Kongens Lyngby, Hovedstaden, Denmark.
Uffe H MortensenDepartment of Biotechnology and Biomedicine, Section for Synthetic Biology, Technical University of Denmark, Kongens Lyngby, Hovedstaden, Denmark.
Technical University of Denmark · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Halophilic and osmotolerant yeast

Indexed as

CRISPR-Cas9;CUG clade;homologous recombination;KU70panARS;

Identifiers

PMID34746438
PMCPMC8566172
OpenAlexW3206799523

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.